Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in Human Pathology
- Vol. 32 (9) , 910-917
- https://doi.org/10.1053/hupa.2001.27108
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Case selection for interferon treatment of hepatitis CJournal of Gastroenterology and Hepatology, 2000
- Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in JapanAnnals of Internal Medicine, 1999
- Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapyCancer, 1999
- Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patientsJournal of Hepatology, 1999
- Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort StudyHepatology, 1998
- Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis CHepatology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Classification of chronic viral hepatitis: a need for reassessmentPublished by Elsevier ,1991
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- A CLASSIFICATION OF CHRONIC HEPATITISThe Lancet, 1968